國立虎尾科技大學 |

Clinical Management of Acute Lymphoblastic Leukemia = From Bench to Bedside /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Clinical Management of Acute Lymphoblastic Leukemia/ edited by Mark R. Litzow, Elizabeth A. Raetz.
Reminder of title:	From Bench to Bedside /
other author:	Litzow, Mark R.
Description:	XI, 437 p. 29 illus., 22 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Internal medicine. -
Online resource:	https://doi.org/10.1007/978-3-030-85147-7
ISBN:	9783030851477

Clinical Management of Acute Lymphoblastic Leukemia = From Bench to Bedside /
Clinical Management of Acute Lymphoblastic LeukemiaFrom Bench to Bedside /[electronic resource] :edited by Mark R. Litzow, Elizabeth A. Raetz. - 1st ed. 2022. - XI, 437 p. 29 illus., 22 illus. in color.online resource.

TRANSLATIONAL SCIENCE -- Molecular pathways and targets in B cell progenitor acute lymphoblastic leukemia -- Genetic Mechanisms in T-Cell Acute Lymphoblastic Leukemia -- Minimal Residual Disease in Acute Lymphoblastic Leukemia – Techniques and Application -- THERAPEUTICS -- Treatment of Pediatric B and T cell ALL -- Treatment of Adult B and T cell Acute Lymphoblastic Leukemia: An Overview of Current Treatments and Novel Advances -- Acute Lymphoblastic Leukemia in Infants: A distinctive, high risk subtype of childhood ALL -- Treatment of Elderly Patients with Acute Lymphoblastic Leukemia -- Treatment of Childhood Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia -- Treatment of adult Philadelphia chromosome positive ALL -- Treatment of Ph-like ALL -- Prophylaxis and treatment of central nervous system (CNS) ALL -- Late effects of therapy of acute lymphoblastic leukemia -- NEW AND EXISTING MODALITIES OF THERAPY -- Monoclonal Antibody Based Treatment and Other New Agents for B-Lineage ALL -- New Agents for the Treatment of T-Cell ALL -- The development and management of treatment with chimeric-antigen receptor T cell (CAR-T) -- Hematopoietic Stem Cell Transplantation in Adults with Acute Lymphoblastic Leukemia (ALL) -- Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia.

This book provides a state-of-the-art overview of acute lymphoblastic leukemia (ALL). The first section of the book presents the translational science behind ALL, reviewing molecular pathways and targets in B- and T-cell ALL, as well as techniques and application of minimal residual disease testing. The second section spotlights ALL management strategies for patients across the spectrum, from infants to the elderly. The final section outlines current and new advances in ALL treatment, including new monoclonal antibodies and allogenic and autologous HSCT. Written by experts in the field, Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside is a valuable resource that will guide patient management, stimulate investigative efforts, and increase understanding of the biologic underpinnings of the disease.

ISBN: 9783030851477

Standard No.: 10.1007/978-3-030-85147-7doiSubjects--Topical Terms:

644638
Internal medicine.

LC Class. No.: RC1-1245

Dewey Class. No.: 616

Clinical Management of Acute Lymphoblastic Leukemia = From Bench to Bedside /
LDR:03635nam a22004455i 4500 001 1091943
003 DE-He213
005 20220113145225.0
007 cr nn 008mamaa
008 221228s2022 sz | s |||| 0|eng d
020 $a 9783030851477 $9 978-3-030-85147-7
024 7 $a 10.1007/978-3-030-85147-7 $2 doi
035 $a 978-3-030-85147-7
050 4 $a RC1-1245
050 4 $a RC1-1245
072 7 $a MJ $2 bicssc
072 7 $a MJ $2 bicssc
072 7 $a MED038000 $2 bisacsh
072 7 $a MJ $2 thema
072 7 $a MJ $2 thema
082 0 4 $a 616 $2 23
082 0 4 $a 616 $2 23
245 1 0 $a Clinical Management of Acute Lymphoblastic Leukemia $h [electronic resource] : $b From Bench to Bedside / $c edited by Mark R. Litzow, Elizabeth A. Raetz.
250 $a 1st ed. 2022.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a XI, 437 p. 29 illus., 22 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a TRANSLATIONAL SCIENCE -- Molecular pathways and targets in B cell progenitor acute lymphoblastic leukemia -- Genetic Mechanisms in T-Cell Acute Lymphoblastic Leukemia -- Minimal Residual Disease in Acute Lymphoblastic Leukemia – Techniques and Application -- THERAPEUTICS -- Treatment of Pediatric B and T cell ALL -- Treatment of Adult B and T cell Acute Lymphoblastic Leukemia: An Overview of Current Treatments and Novel Advances -- Acute Lymphoblastic Leukemia in Infants: A distinctive, high risk subtype of childhood ALL -- Treatment of Elderly Patients with Acute Lymphoblastic Leukemia -- Treatment of Childhood Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia -- Treatment of adult Philadelphia chromosome positive ALL -- Treatment of Ph-like ALL -- Prophylaxis and treatment of central nervous system (CNS) ALL -- Late effects of therapy of acute lymphoblastic leukemia -- NEW AND EXISTING MODALITIES OF THERAPY -- Monoclonal Antibody Based Treatment and Other New Agents for B-Lineage ALL -- New Agents for the Treatment of T-Cell ALL -- The development and management of treatment with chimeric-antigen receptor T cell (CAR-T) -- Hematopoietic Stem Cell Transplantation in Adults with Acute Lymphoblastic Leukemia (ALL) -- Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia.
520 $a This book provides a state-of-the-art overview of acute lymphoblastic leukemia (ALL). The first section of the book presents the translational science behind ALL, reviewing molecular pathways and targets in B- and T-cell ALL, as well as techniques and application of minimal residual disease testing. The second section spotlights ALL management strategies for patients across the spectrum, from infants to the elderly. The final section outlines current and new advances in ALL treatment, including new monoclonal antibodies and allogenic and autologous HSCT. Written by experts in the field, Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside is a valuable resource that will guide patient management, stimulate investigative efforts, and increase understanding of the biologic underpinnings of the disease.
650 0 $a Internal medicine. $3 644638
650 1 4 $a Internal Medicine. $3 668583
700 1 $a Litzow, Mark R. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1399633
700 1 $a Raetz, Elizabeth A. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1399634
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030851460
776 0 8 $i Printed edition: $z 9783030851484
776 0 8 $i Printed edition: $z 9783030851491
856 4 0 $u https://doi.org/10.1007/978-3-030-85147-7
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)